nach oben

Erschienen in:

25.03.2019 | Original Article

The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy

verfasst von: Stefania Zamboni, Marco Moschini, Andrea Gallina, Renzo Colombo, Francesco Montorsi, Alberto Briganti, Andrea Salonia, Alessandro Antonelli, Claudio Simeone, Sandra Belotti, Luca Cristinelli, Agostino Mattei, Philipp Baumeister

Erschienen in: World Journal of Urology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the role of a complete transurethral resection of bladder tumors (c-TURBT) on oncological outcomes after radical cystectomy (RC) and its relationship with adverse pathological features.

Methods

We retrospectively analyzed data of 727 patients treated with RC and bilateral pelvic lymph node dissection at three tertiary referral centers. Possible c-TURBT was reported by the treating surgeon. Multivariable Cox regression analyses were used to assess the relationship of c-TURBT and survival outcomes after surgery in 1:1 propensity score-matched cohort adjusted for age and gender. Moreover, multivariable logistic regression (MVA) was built to predict the relationship between c-TURBT and pT3–T4 stages at RC, lymph node invasion (LNI) and positive soft tissue surgical margin (STSM).

Results

A total of 433 (60%) patients received a c-TURBT. 3.0% of patients with a c-TURBT achieved a pT0–pTa–pTis status vs. 2.0% of patients with incomplete TURBT. At multivariable Cox regression analyses, c-TURBT was not associated with survival outcomes. At MVA, incompleteness of TURBT was significantly associated with a pT3–T4 stage [odds ratio (OR) 8.04, 95% confidence interval (CI) 2.33–27.67, p = 0.001]. No significant association was found between c-TURBT, LNI and STSM.

Conclusion

We found a low rate of achievement of pT0 stage at RC. An incomplete TURBT before RC represented a predictor of pT3–T4 stages, but no effect of a c-TURBT was shown on survival outcomes. Given the current inadequacy of clinical staging strategies with more than 50% of extravesical disease being under-staged, our results could improve patients selection for NAC, driving the decision-making in doubtful cases.

Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442 CrossRef

Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. https://doi.org/10.1016/j.eururo.2016.05.041 CrossRefPubMed

Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G et al (2012) Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int 109:1666–1673. https://doi.org/10.1111/j.1464-410X.2011.10571.x CrossRefPubMed

Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185–190. https://doi.org/10.1016/j.eururo.2010.03.007 CrossRefPubMed

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP et al (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol 198:552–559. https://doi.org/10.1016/j.juro.2017.04.086 CrossRefPubMedPubMedCentral

Alfred Witjes J, Lebret T, Compérat EM, Cowan NC, De Santis M, Bruins HM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71:462–475. https://doi.org/10.1016/j.eururo.2016.06.020 CrossRefPubMed

Mostofi FK, Sobin LH, Torloni H, World Health Organization (1973) Histological typing of urinary bladder tumours. In: Mostofi FK (ed) Collaboration with Sobin LH, Torloni H, and pathologists in fourteen countries. World Health Organization, Geneva

Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13:143–153. https://doi.org/10.1177/106689690501300203 CrossRefPubMed

Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105:1402–1412. https://doi.org/10.1111/j.1464-410X.2010.09217.x CrossRefPubMed

10.

Moschini M, D’Andrea D, Korn S, Irmak Y, Soria F, Compérat E et al (2017) Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol 14:651–668. https://doi.org/10.1038/nrurol.2017.125 CrossRefPubMed

11.

AJCC Cancer Staging Manual. In: Greene FL (eds). Springer (2018). https://www.springer.com/us/book/9781475736564. Accessed 3 Oct 2018

12.

Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523–531CrossRef

13.

Avallone MA, Sack BS, El-Arabi A, Charles DK, Herre WR, Radtke AC et al (2017) Ten-year review of perioperative complications after transurethral resection of bladder tumors: analysis of monopolar and plasmakinetic bipolar cases. J Endourol 31:767–773. https://doi.org/10.1089/end.2017.0056 CrossRefPubMedPubMedCentral

14.

Comploj E, Dechet CB, Mian M, Trenti E, Palermo S, Lodde M et al (2014) Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer. World J Urol 32:1219–1223. https://doi.org/10.1007/s00345-013-1197-x CrossRefPubMed

15.

Herkommer K, Hofer C, Gschwend JE, Kron M, Treiber U (2012) Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors. J Urol 187:1566–1570. https://doi.org/10.1016/j.juro.2011.12.114 CrossRefPubMed

16.

Balbay MD, Cimentepe E, Unsal A, Bayrak O, Koç A, Akbulut Z (2005) The actual incidence of bladder perforation following transurethral bladder surgery. J Urol 174:2260–2262. https://doi.org/10.1097/01.ju.0000181811.61199.35(discussion 2262–2263) CrossRefPubMed

17.

Adiyat KT, Katkoori D, Soloway CT, De los Santos R, Manoharan M, Soloway MS (2010) “Complete transurethral resection of bladder tumor”: are the guidelines being followed? Urology 75:365–367. https://doi.org/10.1016/j.urology.2009.08.082 CrossRefPubMed

18.

Lee SE, Jeong IG, Ku JH, Kwak C, Lee E, Jeong JS (2004) Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor. Urology 63:873–877. https://doi.org/10.1016/j.urology.2003.12.035(discussion 877) CrossRefPubMed

19.

Mowatt G, N’Dow J, Vale L, Nabi G, Boachie C, Cook JA et al (2011) Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 27:3–10. https://doi.org/10.1017/S0266462310001364 CrossRefPubMed

20.

Cauberg ECC, Kloen S, Visser M, de la Rosette JJMCH, Babjuk M, Soukup V et al (2010) Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology 76:658–663. https://doi.org/10.1016/j.urology.2009.11.075 CrossRefPubMed

21.

Hahn RG (1995) Transurethral resection syndrome after transurethral resection of bladder tumours. Can J Anaesth 42:69–72. https://doi.org/10.1007/BF03010574 CrossRefPubMed

22.

Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162:74–76. https://doi.org/10.1097/00005392-199907000-00018 CrossRefPubMed

23.

Haleblian GE, Skinner EC, Dickinson MG, Lieskovsky G, Boyd SD, Skinner DG (1998) Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol 160:2011–2014CrossRef

24.

Bartsch GC, Kuefer R, Gschwend JE, de Petriconi R, Hautmann RE, Volkmer BG (2007) Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. Eur Urol 51:690–697. https://doi.org/10.1016/j.eururo.2006.07.009(discussion 697–698) CrossRefPubMed

25.

Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S et al (2014) Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol 191:40–47. https://doi.org/10.1016/j.juro.2013.07.061 CrossRefPubMed

26.

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19:666–675. https://doi.org/10.1200/JCO.2001.19.3.666 CrossRefPubMed

27.

Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF (2009) Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol 182:2182–2187. https://doi.org/10.1016/j.juro.2009.07.017 CrossRefPubMed

28.

Umbreit EC, Crispen PL, Shimko MS, Farmer SA, Blute ML, Frank I (2010) Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma. Cancer 116:3399–3407. https://doi.org/10.1002/cncr.25202 CrossRefPubMed

Titel: The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy
verfasst von: Stefania Zamboni
Marco Moschini
Andrea Gallina
Renzo Colombo
Francesco Montorsi
Alberto Briganti
Andrea Salonia
Alessandro Antonelli
Claudio Simeone
Sandra Belotti
Luca Cristinelli
Agostino Mattei
Philipp Baumeister
Publikationsdatum: 25.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 12/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-02734-6

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

Imaging modalities in synchronous oligometastatic prostate cancer

Treatment of the primary tumor in metastatic prostate cancer

Risk factors affecting post-pubertal high serum follicle-stimulating hormone in patients with hypospadias

Developments in oligometastatic hormone-sensitive prostate cancer

Pattern of metastatic deposit in recurrent prostate cancer: a whole-body MRI-based assessment of lesion distribution and effect of primary treatment

Patients choose certainty over burden in bladder cancer surveillance

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie